These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17764936)

  • 1. Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-design.
    Larsen SD; Poel TJ; Filipski KJ; Kohrt JT; Pfefferkorn JA; Sorenson RJ; Tait BD; Askew V; Dillon L; Hanselman JC; Lu GH; Robertson A; Sekerke C; Kowala MC; Auerbach BJ
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5567-72. PubMed ID: 17764936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia.
    Pfefferkorn JA; Choi C; Larsen SD; Auerbach B; Hutchings R; Park W; Askew V; Dillon L; Hanselman JC; Lin Z; Lu GH; Robertson A; Sekerke C; Harris MS; Pavlovsky A; Bainbridge G; Caspers N; Kowala M; Tait BD
    J Med Chem; 2008 Jan; 51(1):31-45. PubMed ID: 18072721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase.
    Bratton LD; Auerbach B; Choi C; Dillon L; Hanselman JC; Larsen SD; Lu G; Olsen K; Pfefferkorn JA; Robertson A; Sekerke C; Trivedi BK; Unangst PC
    Bioorg Med Chem; 2007 Aug; 15(16):5576-89. PubMed ID: 17560788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors.
    Pfefferkorn JA; Song Y; Sun KL; Miller SR; Trivedi BK; Choi C; Sorenson RJ; Bratton LD; Unangst PC; Larsen SD; Poel TJ; Cheng XM; Lee C; Erasga N; Auerbach B; Askew V; Dillon L; Hanselman JC; Lin Z; Lu G; Robertson A; Olsen K; Mertz T; Sekerke C; Pavlovsky A; Harris MS; Bainbridge G; Caspers N; Chen H; Eberstadt M
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4538-44. PubMed ID: 17574412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.
    Park WK; Kennedy RM; Larsen SD; Miller S; Roth BD; Song Y; Steinbaugh BA; Sun K; Tait BD; Kowala MC; Trivedi BK; Auerbach B; Askew V; Dillon L; Hanselman JC; Lin Z; Lu GH; Robertson A; Sekerke C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1151-6. PubMed ID: 18155906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Sarver RW; Bills E; Bolton G; Bratton LD; Caspers NL; Dunbar JB; Harris MS; Hutchings RH; Kennedy RM; Larsen SD; Pavlovsky A; Pfefferkorn JA; Bainbridge G
    J Med Chem; 2008 Jul; 51(13):3804-13. PubMed ID: 18540668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distribution.
    Pfefferkorn JA; Litchfield J; Hutchings R; Cheng XM; Larsen SD; Auerbach B; Bush MR; Lee C; Erasga N; Bowles DM; Boyles DC; Lu G; Sekerke C; Askew V; Hanselman JC; Dillon L; Lin Z; Robertson A; Olsen K; Boustany C; Atkinson K; Goosen TC; Sahasrabudhe V; Chupka J; Duignan DB; Feng B; Scialis R; Kimoto E; Bi YA; Lai Y; El-Kattan A; Bakker-Arkema R; Barclay P; Kindt E; Le V; Mandema JW; Milad M; Tait BD; Kennedy R; Trivedi BK; Kowala M
    Bioorg Med Chem Lett; 2011 May; 21(9):2725-31. PubMed ID: 21183342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors.
    Pfefferkorn JA; Choi C; Song Y; Trivedi BK; Larsen SD; Askew V; Dillon L; Hanselman JC; Lin Z; Lu G; Robertson A; Sekerke C; Auerbach B; Pavlovsky A; Harris MS; Bainbridge G; Caspers N
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4531-7. PubMed ID: 17574411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia.
    da Silva VB; Taft CA; Silva CH
    J Phys Chem A; 2008 Mar; 112(10):2007-11. PubMed ID: 18044855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
    Pak VV; Koo M; Yun L; Kwon DY
    J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Schistosoma mansoni 3-hydroxymethylglutaryl-coenzyme-A reductase has different inhibitor kinetics compared to the mammalian host enzyme.
    El-Meanawy A; Hammd H; Chen GZ; Rottman F; Bennett JL
    Trop Gastroenterol; 2005; 26(3):132-5. PubMed ID: 16512462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone.
    Pak VV; Koo M; Kim MJ; Yun L; Kwon DY
    Bioorg Med Chem; 2008 Feb; 16(3):1309-18. PubMed ID: 17977732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a 3,3-diphenylpentane skeleton as a multi-template for creation of HMG-CoA reductase inhibitors.
    Hosoda S; Matsuda D; Tomoda H; Hashimoto M; Aoyama H; Hashimoto Y
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4228-31. PubMed ID: 19502059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase lower fecundity in the German cockroach: correlation between the effects on fecundity in vivo with the inhibition of enzymatic activity in embryo cells.
    Zapata R; Piulachs MD; Bellés X
    Pest Manag Sci; 2003 Oct; 59(10):1111-7. PubMed ID: 14561068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide design of a competitive inhibitor for HMG-CoA reductase based on statin structure.
    Pak VV; Kim SH; Koo M; Lee N; Shakhidoyatov KM; Kwon DY
    Biopolymers; 2006; 84(6):586-94. PubMed ID: 16886212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.
    Hedl M; Rodwell VW
    Protein Sci; 2004 Jun; 13(6):1693-7. PubMed ID: 15152097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide fragmentation as an approach in modeling of an active peptide and designing a competitive inhibitory peptide for HMG-CoA reductase.
    Pak VV; Koo M; Kwon DY; Shakhidoyatov KM; Yun L
    Bioorg Med Chem; 2010 Jun; 18(12):4300-9. PubMed ID: 20494585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
    Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
    Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of pharmacophoric model of condensed pyridine and pyrimidine analogs as hydroxymethyl glutaryl coenzyme A reductase inhibitors.
    Saxena M; Soni LK; Gupta AK; Wakode SR; Saxena AK; Kaskhedikar SG
    Indian J Biochem Biophys; 2006 Feb; 43(1):32-6. PubMed ID: 16955749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors.
    Lin R; Chiu G; Yu Y; Connolly PJ; Li S; Lu Y; Adams M; Fuentes-Pesquera AR; Emanuel SL; Greenberger LM
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4557-61. PubMed ID: 17574416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.